Rain Therapeutics
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Rain Therapeutics generated cash of -$63,199,000, which is less than the previous year. Cash used in financing activities reached the amount of $53,180 last year. Net change in cash is therefore $37,175,000.

Cash Flow

Rain Therapeutics Inc. (NASDAQ:RAIN): Cash Flow
2019 -11.18M -144K 2.5M
2020 -11.23M -5.19M 69.49M
2021 -37.46M -118.23M 121.61M
2022 -63.19M 47.19M 53.18K

RAIN Cash Flow Statement (2019 โ€“ 2022)

2022 2021 2020 2019
Cash at beginning of period
24.78M58.86M5.79M14.62M
Operating activities
Net income
-75.72M-51.39M-21.08M-10.90M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
80K71K52K28K
Stock-based compensation expense
4.85M3.09M865K236K
Deferred income tax benefit 4.85M3.09M865K236K
Changes in operating assets and liabilities:
Accounts receivable, net
0000
Inventories
0000
Accounts payable
1.03M5.28M555K-249K
Cash generated by operating activities
-63.19M-37.46M-11.23M-11.18M
Investing activities
Purchases Of Investments
-76.19M-163.55M00
Investments In Property Plant And Equipment
-8K-2.62M-5.19M-144K
Acquisitions Net
-47.20K2.5M00
Cash generated by investing activities
47.19M-118.23M-5.19M-144K
Financing activities
Common Stock Issued
0133.36M1K0
Payments for dividends
0000
Repurchases of common stock
0000
Repayments of term debt
0000
Cash used in financing activities
53.18K121.61M69.49M2.5M
Net Change In Cash
37.17M-34.08M53.06M-8.82M
Cash at end of period
61.95M24.78M58.86M5.79M
Data sourceData source